Washington Trust’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-400
Closed -$51.2K 461
2025
Q1
$51.2K Sell
400
-116
-22% -$15.7K ﹤0.01% 403
2024
Q4
$68.2K Hold
516
﹤0.01% 396
2024
Q3
$75.1K Sell
516
-40
-7% -$5.79K ﹤0.01% 388
2024
Q2
$76.3K Hold
556
﹤0.01% 385
2024
Q1
$76.3K Sell
556
-40
-7% -$5.46K ﹤0.01% 393
2023
Q4
$81K Buy
596
+405
+212% +$49.4K ﹤0.01% 360
2023
Q3
$23.4K Hold
191
﹤0.01% 516
2023
Q2
$24.2K Sell
191
-180
-49% -$23.4K ﹤0.01% 539
2023
Q1
$47.9K Hold
371
﹤0.01% 421
2022
Q4
$48.7K Hold
371
﹤0.01% 405
2022
Q3
$43K Hold
371
﹤0.01% 415
2022
Q2
$44K Hold
371
﹤0.01% 425
2022
Q1
$48K Hold
371
﹤0.01% 440
2021
Q4
$57K Hold
371
﹤0.01% 417
2021
Q3
$60K Buy
371
+75
+25% +$12.6K ﹤0.01% 493
2021
Q2
$48K Sell
296
-140
-32% -$21.6K ﹤0.01% 529
2021
Q1
$66K Buy
436
+71
+19% +$11.3K ﹤0.01% 452
2020
Q4
$55K Hold
365
﹤0.01% 473
2020
Q3
$49K Buy
365
+140
+62% +$19K ﹤0.01% 449
2020
Q2
$30K Sell
225
-138
-38% -$17.6K ﹤0.01% 482
2020
Q1
$39K Buy
+363
New +$41.8K ﹤0.01% 428
2018
Q3
Sell
-225
Closed -$25K 497
2018
Q2
$25K Buy
+225
New +$24.1K ﹤0.01% 527

Other funds holding IBB

Washington Trust's IBB Position: Q2 2025 in Review

Washington Trust sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 400 shares — an estimated $51.2K sold.

Washington Trust first reported a position in IBB in Q2 2018 and held it in 22 quarters. The position peaked at $81K in Q4 2023. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

  • Washington Trust reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • Washington Trust sold 400 iShares Biotechnology ETF shares in Q2 2025, an estimated $51.2K.
  • Washington Trust first reported a position in iShares Biotechnology ETF in Q2 2018 and held it in 22 quarters.
  • Washington Trust's iShares Biotechnology ETF position peaked at $81K in Q4 2023.
  • 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.